These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7030018)
21. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension]. Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162 [TBL] [Abstract][Full Text] [Related]
22. [Experience with combined therapy in the treatment of glaucoma: guanethidine/epinephrine compared with timolol/epinephrine (author's transl)]. Merkle W Klin Monbl Augenheilkd; 1981 Dec; 179(6):424-5. PubMed ID: 7343723 [TBL] [Abstract][Full Text] [Related]
23. [Ocular hypotensive effect of low doses of timolol]. Erichev VP; Salminen L; Maĭchuk IuF Vestn Oftalmol; 1987; 103(6):15-7. PubMed ID: 3328383 [No Abstract] [Full Text] [Related]
24. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure. Duff GR Acta Ophthalmol (Copenh); 1987 Oct; 65(5):618-21. PubMed ID: 3321878 [TBL] [Abstract][Full Text] [Related]
25. [Metipranolol 0.1%: effect of a single dose on the nycthemeral pressure curve in an eye with chronic primary open-angle glaucoma]. Demailly P; Lecherpie F J Fr Ophtalmol; 1987; 10(6-7):447-9. PubMed ID: 2891739 [TBL] [Abstract][Full Text] [Related]
26. [Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration]. Kawase K; Yamamoto T; Muramatsu T; Ono J; Nakajima T; Matsuhisa A; Sugiura T; Migita M; Ishikawa Y Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):976-82. PubMed ID: 21141077 [TBL] [Abstract][Full Text] [Related]
27. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma]. Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134 [TBL] [Abstract][Full Text] [Related]
28. [The influence of metoprolol eye drops on intraocular pressure (author's transl)]. Bucheli J; Aeschlimann J; Gloor B Klin Monbl Augenheilkd; 1980; 177(2):146-50. PubMed ID: 7005514 [TBL] [Abstract][Full Text] [Related]
29. [Studies on the treatment of glaucomatous eyes with carteolol ophthalmic solution (author's transl)]. Negishi C; Uesugi Y; Kanai A; Nakajima A; Kitazawa Y Nippon Ganka Gakkai Zasshi; 1981 May; 85(5):337-41. PubMed ID: 7270359 [No Abstract] [Full Text] [Related]
30. [Local subjective tolerance of levobunolol and metipranolol in a double-blind comparative study in patients with increased intraocular pressure]. Ober M; Scharrer A; Novack GD; Lue JC Ophthalmologica; 1986; 192(3):159-64. PubMed ID: 2873545 [TBL] [Abstract][Full Text] [Related]
31. [Mid-term results of a double-blind study comparing metipranolol to timolol in the treatment of primary open-angle glaucoma]. Ecoffet M; Demailly P J Fr Ophtalmol; 1987; 10(6-7):451-4. PubMed ID: 2891740 [TBL] [Abstract][Full Text] [Related]
32. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers. Brazier DJ; Smith SE Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009 [TBL] [Abstract][Full Text] [Related]
33. Ocular hypotensive effect of 8-hydroxycarteolol, a metabolite of carteolol. Sugiyama K; Enya T; Kitazawa Y Int Ophthalmol; 1989 Jan; 13(1-2):85-9. PubMed ID: 2744958 [TBL] [Abstract][Full Text] [Related]
34. [Effect of 0.004% travoprost and 2% carteolol on intraocular pressure in patients with ocular hypertension after laser peripheral iridotomy or trabeculectomy in primary angle-closure glaucoma]. Yao BQ; Pang YY; Li YX Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):340-4. PubMed ID: 23900094 [TBL] [Abstract][Full Text] [Related]
35. [Clinical experiences with carteolol in patients with essential hypertension]. Viehmann P Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. Trinquand C; Romanet JP; Nordmann JP; Allaire C; J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585 [TBL] [Abstract][Full Text] [Related]
37. [Influence on ocular surface and intraocular pressure of switching from preservative-containing to preservative-free carteolol hydrochloride ophthalmic solution]. Chikama T; Araie M; Nishida T Nippon Ganka Gakkai Zasshi; 2013 May; 117(5):419-26. PubMed ID: 23855234 [No Abstract] [Full Text] [Related]
38. Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs. Pillunat LE; Stodtmeister R Surv Ophthalmol; 1989 Apr; 33 Suppl():465-6; discussion 471-2. PubMed ID: 2568699 [No Abstract] [Full Text] [Related]
39. [Effect of carteolol and timolol eyedrops on the pressure tolerance of the optic nerve head]. Stodtmeister R; Pillunat L; Wilmanns I; Neubrand M; Finger B; Tobias G Ophthalmologica; 1989; 198(2):64-77. PubMed ID: 2710502 [TBL] [Abstract][Full Text] [Related]
40. Two blind randomized cross-over trials in the treatment of primary open angle glaucoma. Mills KB; Hercules B; English M Trans Ophthalmol Soc U K (1962); 1981; 101 (Pt 4)():397-402. PubMed ID: 6764321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]